Abstract
A short course of antimicrobial therapy should be the aim of all treatment unless otherwise indicated. Factors allowing short treatment courses are those that depend on the host, on the infection and on the agents administered. In essence, immunodeficiencies, long-standing infections, abscesses, or infections associated with foreign bodies cannot be treated with short-course therapies. Bactericidal antibiotics are the only agents suitable for short-course therapy. Many severe infections such as primary bacteraemia and bacteraemia complicating pneumonia, acute pyelonephritis and meningitis are amendable to short-course therapy, whilst others are not. The benefits of short-duration therapy are obvious and may contribute to halting resistance, reduced costs and rational patient management.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.